Rhinoplasty Treatment Market Introduction
Rhinoplasty is plastic surgery of the nose for restorative, reconstructive, or cosmetic purpose. It is a type of the plastic surgery that changes the shape of the nose. The motivation of the surgery may be to improve breathing, change the appearance of the nose, or both. The lower portion of the nose is cartilage and the upper portion of the nose is bone. Rhinoplasty can change cartilage, skin, bone, or all three. Rhinoplasty can change the shape, size, or properties of the nose. It may be performed to repair deformities from an injury, improve some breathing difficulties, or correct a birth defect. Rhinoplasty occupies a high percentage in the field of facial aesthetic surgery. The common side effects of rhinoplasty include infection, an adverse reaction to the anesthesia, and bleeding. Rhinoplasty treatment is classified as closed rhinoplasty treatment and open rhinoplasty treatment.
Report Overview @
Global Rhinoplasty Treatment Market: Competitive Landscape
Allergan plc
Founded in 2013, Allergan plc is based in Dublin, Ireland. It is a global leader in development, manufacture, marketing, and distribution of specialty pharmaceutical products, medical aesthetics, biosimilars, and over-the-counter pharmaceutical products. The company offers products and services in key health care specialties such as the central nervous system, eye care, dermatology, gastroenterology, women’s health, urology, and anti-infective therapeutics category. The company markets its dermatology therapeutics product under the U.S. Specialized Therapeutics segment.
To Know the Segments Analyzed in the Rhinoplasty Treatment Market Report, Ask for a Brochure here
Styker
Founded in 1941, Stryker is based in Kalamazoo, U.S. It is a global medical device company that operates through three business segments: Orthopedics, MedSurg, and Neurotechnology & Spine. The company is one of the leading players in the medical devices market. The company offers a range of products such as implants used in orthopedic implants, trauma, and replacement surgeries; endoscopic and communication systems; emergency medical equipment and intensive care disposable products; surgical equipment and surgical navigation systems; and other products.
Spirox (Entellus Medical Inc.)
Incorporated in 2012, Spirox is based in California, U.S. It is an ENT medical device technology company. The company manufactures its products to improve the quality of life suffering from nasal obstruction. In July 2017, Entellus Medical, Inc. announced to enter a definitive agreement to acquire Spirox, Inc. Spirox, Inc. is engaged in manufacture and marketing of LATERA, an absorbable nasal implant used for the treatment of nasal airway obstruction. This acquisition was aimed to strengthen Entellus Medical, Inc.’s product portfolio in the ENT surgical equipment segment.
Global Rhinoplasty Treatment Market: Dynamics
Increase in Number of Various Cosmetic Surgeries to Drive Rhinoplasty Treatment Market
A key factor driving the growth of the rhinoplasty treatment market is the increase in number of various cosmetic surgeries across the globe. According to the National Center for Biotechnology Information, over the past few years, the number of cosmetic surgeries including rhinoplasty, tummy tuck, breast augmentation, liposuction, and eyelid surgery is increasing dramatically in Saudi Arabia. The younger generation is undergoing cosmetic surgeries such as rhinoplasty and breast augmentation. According to the statistics of the International Study on Cosmetic/Aesthetic procedures, over 800,000 surgeries were performed with an increase of 11% in 2017. Additionally, an increase in the number of geriatric population with heavy sleep and snoring problems is expected to drive the global rhinoplasty treatment market during the forecast period.
Pre Book @
North America to Dominate Market
North America is expected to dominate the global rhinoplasty treatment market during the forecast period as it is the hub of the largest number of certified and licensed surgeons in the world. In 2016, about 4,217,862 procedures were performed in the U.S. Europe is expected to be the second largest market for the rhinoplasty treatment as it has trained professionals in cosmetic surgeries as well. According to the International Society of Aesthetic Plastic Surgery (ISAPS) stats, in 2016, 2,524,115 surgeries were performed in Brazil.
No comments:
Post a Comment